14 Nov, EOD - Indian

SENSEX 77580.31 (-0.14)

Nifty 50 23532.7 (-0.11)

Nifty Bank 50179.55 (0.18)

Nifty IT 42390.85 (0.05)

Nifty Midcap 100 54043.1 (0.45)

Nifty Next 50 67408.65 (0.46)

Nifty Pharma 21752 (-0.26)

Nifty Smallcap 100 17601.05 (0.81)

14 Nov, EOD - Global

NIKKEI 225 38311.99 (-0.86)

HANG SENG 19750.03 (1.67)

S&P 5921.75 (0.22)

Login/Signup
LOGIN HERE
Cancel

Jeena Sikho Lifecare Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 535446 | NSE Symbol : JSLL | ISIN : INE0J5801011 | Industry : Pharmaceuticals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
04-Nov-2024 11-Nov-2024 Half Yearly Results To consider and approve the financial results for the period ended September 30, 2024 Jeena Sikho Lifecare Limited has informed the Exchange regarding Outcome of Board Meeting held on November 11, 2024. (As Per NSE Announcement Dated on: 11/11/2024) Jeena Sikho Lifecare Limited has informed the Exchange regarding Revised Outcome of the Board Meeting under Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 dated November 11, 2024 (As Per NSE Announcement Dated on: 12/11/2024)
23-Sep-2024 03-Oct-2024 Acquisitions To discuss and consider the proposal for takeover/ acquisition of related business/ unit Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting held on October 03, 2024. (As Per NSE Announcement Dated on: 03/10/2024)
13-Sep-2024 13-Sep-2024 Disinvestments Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting held on September 13, 2024. regarding Divestment of equity stake in Saatviksuddhi Ayurlife Private Limited by Jeena Sikho Lifecare Limited.
23-Jul-2024 29-Jul-2024 AGM To consider and recommend final dividend on Equity Shares of the company for the financial year ended March 31, 2024. Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting held on July 29, 2024. (As Per NSE Announcement Dated on: 29/07/2024)
10-Jun-2024 10-Jun-2024 Investments Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting held on Jun 10, 2024 regarding investment of 80% in Equity Share Capital of Saatviksuddhi Ayurlife Private Limited .
09-May-2024 15-May-2024 Quarterly Results To consider and approve the Audited Financial Results along with Audit Report for thefinancial year ended March 31, 2024. Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting held on May 15, 2024 for the Approval of the Standalone Audited Financial Results of the Company for the period ended on 31 March, 2024 (As Per NSE Announcement Dated on: 15/05/2024)
30-Apr-2024 29-Apr-2024 Change in Directors Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting for the appointment of Independent Director held on 29th April, 2024 as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
13-Mar-2024 20-Mar-2024 Others To consider and approve the financial results for the period ended December 31, 2023 and other business matters. Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting held on March 20, 2024. (As Per NSE Announcement Dated on: 20/03/2024)
17-Jan-2024 24-Jan-2024 Employee Stock Option To consider and approve the proposal for Employee Stock Option Scheme to be implemented in the company. Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting held on January 24, 2024 for recommendation of Employee Stock Option Scheme and alteration in the Memorandum of Association of the company. (As Per NSE Announcement Dated on: 24/01/2024)
31-Oct-2023 04-Nov-2023 Bonus Issue To consider and approve allotment of 1,10,48,954 fully paid-up Bonus shares to all the shareholders holding shares as on the Record date November 02, 2023. Jeena Sikho Lifecare Limited has informed the Exchange that the Board of Directors of the Company has approved the allotment of 1,10,48,954 (One Crore Ten Lakhs Forty-Eight Thousand Nine Hundred and Fifty-Four only) fully paid up Bonus Equity Shares of Rs. 10/- each (As Per NSE Announcement Dated on 04/11/2023)
23-Oct-2023 30-Oct-2023 Half Yearly Results To consider and approve the financial results for the period ended September 30, 2023. Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting held on October 30, 2023. (As Per NSE Announcement Dated on: 30/10/2023)
19-Sep-2023 25-Sep-2023 Bonus Issue To consider issue of Bonus Equity Shares and increase of Authorised Share Capital of the company. Jeena Sikho Lifecare Limited has informed the Exchange about increase in Authorised Capital from Rs. 15.00 crores divided into 1,50,00,000 equity shares of Rs. 10/- each to Rs. 25.00 crores divided into 2,50,00,000 equity shares of Rs. 10/- each (As Per NSE Announcement Dated on: 25/09/2023)
16-Aug-2023 16-Aug-2023 AGM Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting held on August 16, 2023 for approval of convening the AGM including approval of Annual Report and fixation of Record date of final dividend and voting at ensuing AGM.
02-Jun-2023 02-Jun-2023 Change in Other Executives Jeena Sikho Lifecare Limited has informed the Exchange about appointment of Ms. Anshika Garg as company secretary and compliance officer of the Company with immediate effect i.e., 02-06-2023 Jeena Sikho Lifecare Limited has informed the Exchange about resignation of Ms. Nikita Juneja from the position of company secretary and compliance officer with immediate effect i.e., 02/06/2023
22-May-2023 29-May-2023 Accounts To consider and approve the financial results for the period ended March 31, 2023 and recommendation of final dividend JEENA SIKHO LIFECARE LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 29-May-2023 for Dividend Jeena Sikho Lifecare Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2023, recommended Final Dividend of 2 per equity share. Jeena Sikho Lifecare Limited has informed the Exchange regarding Board meeting held on May 29, 2023 to consider and approve financial statements (standalone & consolidated) for the financial year 2022-23. (As Per NSE Announcement Dated on 29/05/2023)
1 2